We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Vaxart Doses First Patients in Trial of Oral Tablet COVID-19 Vaccine
Vaxart Doses First Patients in Trial of Oral Tablet COVID-19 Vaccine
The first participant has been dosed in Vaxart’s phase 1 study of an oral COVID-19 vaccine tablet the company is developing as an alternative to injectable vaccines. If approved, it would be the first-ever vaccine in tablet form.